Insmed Inc. buy JPMorgan Chase & Co.
Start price
20.06.24
/
50%
€62.50
Target price
20.06.25
€67.14
Performance (%)
40.80%
End price
21.06.25
€88.00
Summary
This prediction ended on 21.06.25 with a price of €88.00. The BUY prediction by JPMorgan_Chase___Co_ for Insmed Inc. saw massive gains of 40.80%. JPMorgan_Chase___Co_ has a follow-up prediction for Insmed Inc. where he still thinks Insmed Inc. is a Buy. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Insmed Inc. | 8.800% | 8.800% | 72.152% |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $72.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat
In the thread Trading Insmed Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten